Open Access Government caught up with Dr Mary Stephen, Public Health Expert at the World Health Organization African Region, provides an update on the COVID-19 outbreak in Africa.
Here, we interview Alex Wilson, Co-founder of specialist reagent company PCR Biosystems, discussing how their expertise in enzyme development and large-scale production has been successfully applied to COVID-19 testing solutions around the world.
Florence Fouque from the World Health Organization describes the unpredictability and risks of health systems disruptions due to the impact of climate change on vectors & vector-borne diseases.
A new study confirms that antimicrobial resistance increases as people travel internationally, with one scientist commenting that the world faces "a worrisome problem on the horizon".
The Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that the Pfizer/BioNTech COVID-19 vaccine is safe to use in 12-15-year-olds.
Graham Mimms, Hygiene Aviation Expert and co-founder of Safe Surface Sensor, explains why the only way to stop a future health crisis is to ensure we have strict hygiene policies in place.
The World Health Organisation (WHO) has given emergency approval to the Sinovac COVID-19 vaccine - because there is ongoing "access inequity" for countries in the Global South.
Frances Goodrum, Head of External Affairs, Brooke Action for Working Horses and Donkeys, turns our attention to COVID-19 and the urgent case for a greater focus on One Health.
Kate Edwards, Director at Intelligent Infection Control Services Limited, LumiBio, underlines the importance of creating safe environments for the patient, clinician & support worker in the NHS.
President Biden asked US intelligence agencies to begin investigating the origins of COVID-19 yesterday (26 May) - the international WHO team were unable to access all available data in their March trip to Wuhan.
European Public Health Association Executive Director, Dineke Zeegers Paget, updates us about COVID-19 and its impact on society, public health, healthcare and equitable access to vaccines.
The REACT study suggests that scientists don't know if the Indian variant is more infectious than the Kent variant - largely responsible for the winter wave of deaths.
A new study has found that the second dose of the Pfizer vaccine produces a 3.5-times greater antibody response when given at 12 weeks, compared to three weeks.
